Table I.

Primers used in the current study.

Gene	Primer sequence (5′-3′)
Bcl-2	F: 5′-CACAAGAGGCCAAGGCTACC-3′
	R: 5′-CAGGAAAGCAGGAAGTCTCAA-3′
Bcl-xl	F: 5′-CCAAAATCCCTGCTCTTCATG-3′
	R: 5′-GCATTCTTGGCATCGTTATTCA-3′
Bax	F: 5′-ATTGAGAAACGATTTGCCTAC-3′
	R: 5′-GGAAATGGCTTATTCTCCTTTGCTT-3′
Bad	F: 5′-GGAAACCCGGTGGGGCCAC-3′
	R: 5′-ACCAGTAGCGGGTGGTC-3′
Iba-1	F: 5′-CACCATTAGCTGGGCGTCT-3′
	R: 5′-GATGCGGAAGTAGCAAAAGC-3′
MPO	F: 5′-ATTCTCCACACCCTGTTTCG-3′
	R: 5′-ATGCAGCAGTGTGTCATTCC-3′
TGF-β	F: 5′-GGCCAGATCCTGTCCAAGC-3′
	R: 5′-GTGGGTTTCCACCATTAGCAC-3′
ERK	F: 5′-ACCTAGCCGTGGAGCTTGG-3′
	R: 5′-GCCCTTGGTTGTTTACCTGG-3′
β-actin	F: 5′-AAGGACCTGTATGCCAACACA-3′
	R: 5′-ATCCACACAGAATACTTGCGTT-3′

Bcl-2, B cell lymphoma-2; Bcl-xl, B cell lymphoma-extra large; Bax, Bcl-2-assocaited X protein; Bad, Bcl-2-associated death promoter; Iba-1, ionized calcium binding adaptor molecule 1; MPO, myeloperoxidase; TGF-β; transforming growth factor-β; ERK, extracellular signal-regulated kinase.